Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Aima Inc.
INTERNAL ADDRESS
Suite 3200
*MAILING ADDRESS
650 West Georgia Street
*CITY
Vancouver, BC
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Canada
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
V6B4P7
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Canada
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
003
*IDENTIFICATION
Body and beauty care cosmetics; body and beauty care cosmetics containing cannabinoids; body and beauty care cosmetics containing cannabis;
body and beauty care cosmetics containing cannabis derivatives ; body creams for cosmetic purposes; body lotions for cosmetic purposes; cannabinoid oil for cosmetic purposes; cannabis oil for
cosmetic purposes; cannabis-based cosmetics; CBD cosmetics
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
005
*IDENTIFICATION
menstrual symptom treatment preparations; nutraceutical dietary supplement for maintaining general health and wellbeing; nutraceutical food
and beverages for general health and well-being; nutraceuticals as a sleep aid; nutraceuticals for reducing stress and fatigue; nutraceuticals for relieving anxiety; nutraceuticals for the relief of
epilepsy; nutraceuticals for the relief of pain; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of pain; topical analgesic creams; Pharmaceutical
preparations for the prevention of pain; pharmaceutical preparations for the prevention, treatment, or relief of pain, namely menstrual pain, pre-menstrual pain, peri-menopausal pain, menopausal pain
and post-menopausal pain; suppositories for the prevention, treatment, or relief of pain; suppositories for the prevention, treatment, or relief of pain, namely menstrual pain; vaginal suppositories
for the prevention, treatment, or relief of pain; vaginal suppositories for the prevention, treatment, or relief of pain, namely menstrual pain, pre-menstrual pain, peri-menopausal pain, menopausal
pain and post-menopausal pain; pre-menstrual, peri-menopausal, menopausal, and post-menopausal symptom treatment preparations; pharmaceutical preparations for the prevention, treatment, or relief of
pain, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for the prevention, treatment, or relief of psychological
disorders, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for the treatment, prevention, or relief of inflammation,
muscle cramping or spasticity, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for improving sleep quality or sleep
duration, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids;
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS
009
*IDENTIFICATION
Downloadable software in the nature of computer software or mobile application software for managing, analyzing and storing patient health or
medical information to provide recommendations for products and services in the fields of health and wellbeing and to provide information about clinical trial and drug trial criteria and
qualification.
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a
basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME
Lisa M. Caldwell
ATTORNEY DOCKET NUMBER
22-109682-01
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Klarquist Sparkman, LLP
INTERNAL ADDRESS
One World Trade Center, Suite 1600
STREET
121 SW Salmon Street
CITY
Portland
STATE
Oregon
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
97204-2988
PHONE
503-595-5300
FAX
5035955301
EMAIL ADDRESS
ptotmdocket@klarquist.com
OTHER APPOINTED ATTORNEY
Andrew T. Ball, Lisa M. Caldwell, J. Christopher Carraway, Roy Chamcharas, Kristin L. Cleveland, Robert T. Cruzen, Amy C. Dachtler, Scott E.
Davis, Caroline L. Desmond, James E. Geringer, Michael P. Girard, Susan W. Graf, Claire E. Green, Carsten C. Grellmann, Jeffrey B. Haendler, Klaus H. Hamm, Kevin M. Hayes, Joseph T. Jakubek, Sarah E.
Jelsema, Alexa M. Johnston, Brandon J. Johnson, Cory A. Jones, Michael D. Jones, Deakin T. Lauer, Jie Lian, Jeffrey S. Love, Ziyu Ma, Andrew M. Mason, Gregory L. Maurer, Ethan A. McGrath, Tucker
Mottl, Kyle B. Rinehart, Wayne R. Rupert, Sheree Lynn Rybak, Johanna P. Schwartz, Gregory K. Scott, Robert F. Scotti, Todd M. Siegel, Stacey C. Slater, Shelby A. Stepper, Samuel B. Thacker, Caitlin
A. Thireault, Derrick W. Toddy, John D. Vandenberg, Mark W. Wilson, Garth A. Winn, and Travis Young, all members of the Bar of the State of Oregon
DOMESTIC REPRESENTATIVE INFORMATION
NAME
Lisa M. Caldwell
FIRM NAME
Klarquist Sparkman, LLP
INTERNAL ADDRESS
One World Trade Center, Suite 1600
STREET
121 SW Salmon Street
CITY
Portland
STATE
Oregon
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP CODE
97204-2988
PHONE
503-595-5300
FAX
5035955301
EMAIL ADDRESS
ptotmdocket@klarquist.com
CORRESPONDENCE INFORMATION
NAME
Lisa M. Caldwell
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
ptotmdocket@klarquist.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
lisa.caldwell@klarquist.com; mail@patentable.com
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
3
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
1050
*TOTAL FEES PAID
1050
SIGNATURE INFORMATION
SIGNATURE
/Lanna Lastiwka/
SIGNATORY'S NAME
Lanna Lastiwka
SIGNATORY'S POSITION
CEO
DATE SIGNED
02/23/2023
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97808575
Filing Date:02/23/2023
To the Commissioner for Trademarks:
MARK: AIMA (Standard Characters, see mark)
The literal element of the mark consists of AIMA. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Aima Inc., a corporation of Canada, having an address of
Suite 3200
650 West Georgia Street
Vancouver, BC V6B4P7
Canada
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 003: Body and beauty care cosmetics; body and beauty care cosmetics containing cannabinoids; body and beauty care cosmetics containing cannabis; body and beauty care
cosmetics containing cannabis derivatives ; body creams for cosmetic purposes; body lotions for cosmetic purposes; cannabinoid oil for cosmetic purposes; cannabis oil for cosmetic purposes;
cannabis-based cosmetics; CBD cosmetics
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Canada application number 2226898, filed 12/07/2022.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
International Class 005: menstrual symptom treatment preparations; nutraceutical dietary supplement for maintaining general health and wellbeing; nutraceutical food and beverages for general
health and well-being; nutraceuticals as a sleep aid; nutraceuticals for reducing stress and fatigue; nutraceuticals for relieving anxiety; nutraceuticals for the relief of epilepsy; nutraceuticals
for the relief of pain; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of pain; topical analgesic creams; Pharmaceutical preparations for the
prevention of pain; pharmaceutical preparations for the prevention, treatment, or relief of pain, namely menstrual pain, pre-menstrual pain, peri-menopausal pain, menopausal pain and post-menopausal
pain; suppositories for the prevention, treatment, or relief of pain; suppositories for the prevention, treatment, or relief of pain, namely menstrual pain; vaginal suppositories for the prevention,
treatment, or relief of pain; vaginal suppositories for the prevention, treatment, or relief of pain, namely menstrual pain, pre-menstrual pain, peri-menopausal pain, menopausal pain and
post-menopausal pain; pre-menstrual, peri-menopausal, menopausal, and post-menopausal symptom treatment preparations; pharmaceutical preparations for the prevention, treatment, or relief of pain,
namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for the prevention, treatment, or relief of psychological disorders,
namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for the treatment, prevention, or relief of inflammation, muscle cramping
or spasticity, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for improving sleep quality or sleep duration, namely
tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids;
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Canada application number 2226898, filed 12/07/2022.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
International Class 009: Downloadable software in the nature of computer software or mobile application software for managing, analyzing and storing patient health or medical information to
provide recommendations for products and services in the fields of health and wellbeing and to provide information about clinical trial and drug trial criteria and qualification.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of
priority based on Canada application number 2226898, filed 12/07/2022.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for
registration, a valid claim of priority may be retained.
The owner's/holder's proposed attorney information: Lisa M. Caldwell. Other appointed attorneys are Andrew T. Ball, Lisa M. Caldwell, J. Christopher Carraway, Roy Chamcharas, Kristin L. Cleveland,
Robert T. Cruzen, Amy C. Dachtler, Scott E. Davis, Caroline L. Desmond, James E. Geringer, Michael P. Girard, Susan W. Graf, Claire E. Green, Carsten C. Grellmann, Jeffrey B. Haendler, Klaus H. Hamm,
Kevin M. Hayes, Joseph T. Jakubek, Sarah E. Jelsema, Alexa M. Johnston, Brandon J. Johnson, Cory A. Jones, Michael D. Jones, Deakin T. Lauer, Jie Lian, Jeffrey S. Love, Ziyu Ma, Andrew M. Mason,
Gregory L. Maurer, Ethan A. McGrath, Tucker Mottl, Kyle B. Rinehart, Wayne R. Rupert, Sheree Lynn Rybak, Johanna P. Schwartz, Gregory K. Scott, Robert F. Scotti, Todd M. Siegel, Stacey C. Slater,
Shelby A. Stepper, Samuel B. Thacker, Caitlin A. Thireault, Derrick W. Toddy, John D. Vandenberg, Mark W. Wilson, Garth A. Winn, and Travis Young, all members of the Bar of the State of
Oregon. Lisa M. Caldwell of Klarquist Sparkman, LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
One World Trade Center, Suite 1600
121 SW Salmon Street
Portland, Oregon 97204-2988
United States
503-595-5300(phone)
5035955301(fax)
ptotmdocket@klarquist.com
The docket/reference number is 22-109682-01.
Lisa M. Caldwell submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant hereby appoints Lisa M. Caldwell of Klarquist Sparkman, LLP
121 SW Salmon Street
One World Trade Center, Suite 1600
Portland Oregon 97204-2988
United States
503-595-5300(phone)
5035955301(fax)
ptotmdocket@klarquist.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: /Lanna Lastiwka/ Date: 02/23/2023
Signatory's Name: Lanna Lastiwka
Signatory's Position: CEO
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 97808575
Payment Accounting Date: 02/23/2023
Serial Number: 97808575
Internet Transmission Date: Thu Feb 23 15:04:13 ET 2023
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XX-20230223150414312
766-97808575-8606a7d85b8e8ba655c254f8892
675bada0fe148b2c9e7e8487da1bca7178bea30-
DA-04148419-20230213144257917257